The central target of $8 is calculated from six current, firm-attributed price targets: TD Cowen at $4 (cut from $8 on October 9, 2026), Canaccord Genuity at $7.50 (initiated September 25), Maxim Group at $7 (initiated September 18), Cantor Fitzgerald at $9 (cut from $11 in August), and Northland Securities and Roth MKM each at $10. Their sum is $47.50, giving a mean of about $7.92, rounded to $8. The approximate low-to-high range is $4 to $10.
Because the targets were set at different points during a steep decline, the range is unusually wide. The overall "Strong Buy" consensus and average analyst price target are not a forecast that the shares will trade at $8; rather, they reflect an aggregated 12-month research view. Notably, the most recent revision — TD Cowen's cut to $4 — signals that analysts are marking expectations down as the stock falls, and the mean may overstate current conviction until more firms refresh their models. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The stock closed near $0.96 on November 12, 2026, before surging roughly 67% in after-hours trading toward $1.61 following its third-quarter report. With a market capitalization near $102 million, Merlin trades as a speculative, early-stage company. From the $0.96 close, the move to $8 represents about 730% upside — a very large required advance, not a modest or routine step.
The path toward such a level would depend on the company converting early demonstration work into durable production revenue. Q3 2026 revenue of about $3.5 million rose 58% sequentially, and management pointed to a new $8.9 million task order moving its C-130J autonomy program with U.S. Special Operations Command into the integration phase, plus a $500,000 U.S. Africa Command contract. Still, these figures are small relative to a cost base that generated a roughly $24.1 million adjusted EBITDA loss in the quarter.
The most credible supports are operational. Merlin has now reported three consecutive quarters of sequential revenue growth and a narrowing adjusted EBITDA loss, from about $27.8 million in Q2 to $24.1 million in Q3. The C-130J program is advancing toward flight demonstrations and potential production revenue across a large installed fleet. A clean balance sheet with roughly $161.6 million in cash, equivalents, and short-term investments, and no outstanding debt, gives the company runway to develop its technology without immediate financing pressure. From what I see, this cash position stands out as a key differentiator.
The obstacles are substantial. Merlin's gross margin is negative — cost of revenue exceeded revenue in Q3 — meaning each program currently costs more to deliver than it bills. The headline GAAP net income of $73.8 million was driven almost entirely by a non-cash $103.6 million gain on warrant liabilities, not operating performance. Cash declined by about $22.3 million during the quarter, and the business depends heavily on a small number of U.S. government customers and programs, where budget timing and procurement decisions can delay revenue. The stock also carries a complex capital structure, including warrants and preferred stock that can dilute common holders.
From a technical standpoint, the 52-week range of $0.74 to $17.00 illustrates extreme volatility. The $0.74 area marks a durable support level near the recent low, while the post-earnings after-hours bounce toward $1.61 suggests the $1.60–$2.00 zone could act as initial resistance. Far above, the $8 target sits well below the former $17 high but still requires a multi-fold repricing from current levels.
Analyst price targets generally reflect a roughly 12-month research horizon, though the timing of individual reports varies. Investors should monitor whether the C-130J integration phase completes on schedule, whether the AFRICOM and USSOCOM awards convert into larger funded work, the pace of cash burn and any capital-raising or dilution, and whether additional analysts revise their targets following the price collapse. Fourth-quarter revenue and any formal 2027 expense guidance will be important data points. I'm watching this closely as the next few quarters unfold.
For traders seeking a more systematic approach, Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs and generate Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. I have found this tool helpful in my own process for spotting shifts in high-volatility names like Merlin alongside fundamental and technical work.
The $8 target is an analyst-derived arithmetic mean, not a promise, and it sits far above a stock that has lost most of its value over the past year. The case for a move higher rests on genuine progress — growing defense contracts, sequential revenue gains, and a strong cash cushion — while the case against it rests on negative gross margins, persistent cash burn, government-customer concentration, and the clear risk that analyst targets, already being cut, will be reduced further. Reaching $8 would require a very large repricing that can only be justified by a sustained shift toward profitable production revenue, and no analyst or data point guarantees that outcome.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The RSI Indicator for MRLN moved out of oversold territory on November 06, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 12 similar instances when the indicator left oversold territory. In 7 of the 12 cases the stock moved higher. This puts the odds of a move higher at 58%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 10 of 19 cases where MRLN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 53%.
The Moving Average Convergence Divergence (MACD) for MRLN just turned positive on October 13, 2026. Looking at past instances where MRLN's MACD turned positive, the stock continued to rise in 6 of 14 cases over the following month. The odds of a continued upward trend are 43%.
Following a +28.11% 3-day Advance, the price is estimated to grow further. Considering data from situations where MRLN advanced for three days, in 29 of 74 cases, the price rose further within the following month. The odds of a continued upward trend are 39%.
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MRLN as a result. In 9 of 35 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 26%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MRLN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 64%.
The Aroon Indicator for MRLN entered a downward trend on November 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 18 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.880) is normal, around the industry mean (5.050). P/E Ratio (0.274) is within average values for comparable stocks, (17.247). Projected Growth (PEG Ratio) (0.090) is also within normal values, averaging (3.110). Dividend Yield (0.024) settles around the average of (0.055) among similar stocks. P/S Ratio (23.148) is also within normal values, averaging (18.367).
The Tickeron SMR rating for this company is 48 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 93 (best 1 - 100 worst), indicating slightly worse than average price growth. MRLN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MRLN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of equipment leasing solutions to small businesses
Industry AerospaceDefense